Drug
Polymyxin B
Important: Reactions below are the flagged terms from this drug’s
FAERS report history (min. 3 co-reports per term) — PRR/ROR indicate
disproportionality in spontaneous reporting, not causation.
Data from FDA FAERS via openFDA. Last recalculated: 2026-09-14.
| Reaction | Co-reports (a) | PRR | ROR | Signal | |
|---|---|---|---|---|---|
| 1 | Drug Resistance | 41 | 42.2 | 44.4 | signal |
| 2 | Macular Degeneration | 18 | 39.9 | 40.8 | signal |
| 3 | Multiple Organ Dysfunction Syndrome | 24 | 22.7 | 23.4 | signal |
| 4 | Nephropathy Toxic | 8 | 19.0 | 19.1 | signal |
| 5 | Neurotoxicity | 12 | 18.2 | 18.5 | signal |
| 6 | Cytomegalovirus Infection | 11 | 17.5 | 17.7 | signal |
| 7 | Drug Ineffective For Unapproved Indication | 35 | 16.6 | 17.3 | signal |
| 8 | Disseminated Intravascular Coagulation | 7 | 13.1 | 13.2 | signal |
| 9 | Treatment Failure | 34 | 10.9 | 11.4 | signal |
| 10 | Eosinophilia | 7 | 10.6 | 10.7 | signal |
| 11 | Thrombotic Microangiopathy | 3 | 8.2 | 8.2 | signal |
| 12 | Tuberculosis | 3 | 6.2 | 6.2 | signal |
| 13 | Premature Delivery | 3 | 4.9 | 5.0 | signal |
| 14 | Myelosuppression | 4 | 3.1 | 3.1 | no signal |